Dawei Deng
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 7
- Pancreatic and Hepatic Oncology Research 4
- Cancer Immunotherapy and Biomarkers 2
-
- Cancer Genomics and Diagnostics 1
- Co-authors
- Dong Shang (8 shared papers)Qihang Yuan (4 shared papers)Peiyuan Yin (4 shared papers)Zeming Wu (3 shared papers)Pan Chen (4 shared papers)Jie Ren (2 shared papers)Biao Zhang (2 shared papers)Hong Xiang (3 shared papers)
- Journals
- Frontiers in Oncology (2 papers)Scientific Reports (2 papers)Frontiers in Immunology (2 papers)Natural Product Communications (1 paper)Frontiers in Genetics (1 paper)
- Partner nations
- ChinaNew Zealand
In The Last Decade
Dawei Deng
13 papers receiving 261 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 35
- Oncology 50
- Biochemistry 10
- Pulmonary and Respiratory Medicine 43
- Molecular Biology 85
Countries citing papers authored by Dawei Deng
This map shows the geographic impact of Dawei Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Deng more than expected).
Fields of papers citing papers by Dawei Deng
This network shows the impact of papers produced by Dawei Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Deng. The network helps show where Dawei Deng may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Deng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 94 | |
| 2 | 2021 | 35 | |
| 3 | 2021 | 29 | |
| 4 | 2023 | 23 | |
| 5 | 2010 | 20 | |
| 6 | 2021 | 19 | |
| 7 | 2022 | 19 | |
| 8 | 2023 | 11 | |
| 9 | 2021 | 5 | |
| 10 | 2024 | 5 | |
| 11 | 2025 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2025 | 0 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 |
About Dawei Deng
Dawei Deng is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Applied Psychology, having authored 16 papers that have together received 264 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Pancreatitis Pathology and Treatment (4 papers), RNA modifications and cancer (3 papers), Ferroptosis and cancer prognosis (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Cancer Research (35 citations), Oncology (50 citations), Biochemistry (10 citations), Pulmonary and Respiratory Medicine (43 citations) and Molecular Biology (85 citations). Dawei Deng has collaborated with scholars based in China and New Zealand. Frequent co-authors include Dong Shang, Qihang Yuan, Peiyuan Yin, Zeming Wu, Pan Chen, Jie Ren, Biao Zhang, Hong Xiang, Shuang Li and Fangyue Guo. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, Frontiers in Immunology, Natural Product Communications and Frontiers in Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.